4 February 2020

Apollo agrees to acquire specialty pharmaceutical company Covis Pharma BV

+ 1 other team member

De Brauw has advised Apollo on the acquisition of speciality pharmaceutical company Covis Pharma.

NYSE listed company Apollo Global Management, Inc., a leading global alternative investment manager, has agreed to acquire Netherlands based Covis Pharma BV, a global specialty pharmaceutical company, from Cerberus Capital Management, L.P., a global leader in alternative investing.

Covis Phama is known for its therapeutic solutions for patients with life-threatening conditions and chronic illnesses.

Terms of the transaction were not disclosed. Subject to antitrust approval, the transaction is expected to close by the end of the 1st quarter of 2020.